Quality of life and tolerability in patients with schizophrenia taking atypical antipsychotics

被引:10
|
作者
Fleming, K. [1 ]
Potkin, S. G. [1 ]
Binneman, B. [2 ]
Keller, D. [3 ]
Alphs, L. [4 ]
Panagides, J.
机构
[1] Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA
[2] Pfizer Inc, Clin R&D, Groton, CT USA
[3] Pfizer Inc, Clin Pharmacol & Stat, Groton, CT USA
[4] Pfizer Inc, Global R&D, Ann Arbor, MI USA
关键词
D O I
10.1016/S0924-977X(07)70710-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S466 / S467
页数:2
相关论文
共 50 条
  • [21] Tolerability and efficacy of neuroleptic medication in schizophrenia -: a comparison of "typical" and "atypical" antipsychotics
    Weinmüller, B
    Dose, M
    Glaser, T
    PHARMACOPSYCHIATRY, 2005, 38 (05) : 284 - 284
  • [22] Weight gain and quality of life among patients taking antipsychotics
    Fetter, JC
    PSYCHIATRIC SERVICES, 2003, 54 (07) : 1041 - 1041
  • [23] Quality of life and new antipsychotics in schizophrenia - Are patients better off?
    Awad, AG
    Voruganti, LNP
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 1999, 45 (04) : 268 - 275
  • [24] Quality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics Drugs
    Aurigena Antunes de Araújo
    Diego de Araújo Dantas
    Gemma Galgani do Nascimento
    Susana Barbosa Ribeiro
    Katarina Melo Chaves
    Vanessa de Lima Silva
    Raimundo Fernandes de Araújo
    Dyego Leandro Bezerra de Souza
    Caroline Addison Carvalho Xavier de Medeiros
    Psychiatric Quarterly, 2014, 85 : 357 - 367
  • [25] Quality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics Drugs
    de Araujo, Aurigena Antunes
    Dantas, Diego de Araujo
    do Nascimento, Gemma Galgani
    Ribeiro, Susana Barbosa
    Chaves, Katarina Melo
    Silva, Vanessa de Lima
    de Araujo, Raimundo Fernandes, Jr.
    Bezerra de Souza, Dyego Leandro
    Carvalho Xavier de Medeiros, Caroline Addison
    PSYCHIATRIC QUARTERLY, 2014, 85 (03) : 357 - 367
  • [26] Comparative Profile Of Atypical Antipsychotics In Patients Of Schizophrenia
    Gupta, Sumitabh
    Gupta, Prerana
    Sharma, Mridul
    INDIAN JOURNAL OF PSYCHIATRY, 2018, 60 (05) : 75 - 75
  • [27] Antiaggressive action of atypical antipsychotics in patients with schizophrenia
    Vesce, J
    Comaty, JE
    Advokat, C
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (03) : 353 - 355
  • [28] Patients with schizophrenia taking typical or atypical antipsychotics: Evaluating symptoms with brief psychiatry rating scale
    Uzun, S
    Kozumplik, O
    Mimica, N
    Jukic, V
    Folnegovic-Smalc, V
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 505 - 505
  • [29] Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: A cohort study
    Bai, Ya Mei
    Chen, Tzu Ting
    Yang, Wei-Shiung
    Chi, Yu-Chao
    Lin, Chao-Cheng
    Liou, Ying-Jay
    Wang, Ying-Chieh
    Su, Tung-Ping
    Chou, Pesus
    Chen, Jen-Yeu
    SCHIZOPHRENIA RESEARCH, 2009, 111 (1-3) : 1 - 8
  • [30] Health-related quality of life in patients treated with atypical antipsychotics
    de Almeida, Juliana L.
    Zuppo, Isabella de Figueiredo
    Castel, Saulo
    Reis, Edna A.
    de Oliveira, Helian N.
    Ruas, Cristina M.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) : 599 - 607